Diabetic retinopathy in 2011: further insights from new epidemiological studies and clinical trials.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Effects of intensive glycemic control in ocular complications in patients with type 2 diabetes: a meta-analysis of randomized clinical trials.Endocrine · 2015
   Pooled it
2. Proteomic Analysis of Aqueous Humor Identified Clinically Relevant Molecular Targets for Neovascular Complications in Diabetic Retinopathy.Molecular & cellular proteomics : MCP · 2025
   Article
3. Metabolomic studies reveal and validate potential biomarkers of diabetic retinopathy in two Chinese datasets with type 2 diabetes: a cross-sectional study.Cardiovascular diabetology · 2024
   Article
4. Prevalence of diabetic retinopathy in self-reported diabetics among various ethnic groups and associated risk factors in North-East India: A hospital-based study.Indian journal of ophthalmology · 2021
   Article
5. Protective Effects and Molecular Signaling of n-3 Fatty Acids on Oxidative Stress and Inflammation in Retinal Diseases.Antioxidants (Basel, Switzerland) · 2020
   Review
6. miRNA-451a regulates RPE function through promoting mitochondrial function in proliferative diabetic retinopathy.American journal of physiology. Endocrinology and metabolism · 2019
   Article
7. Haptoglobin2-2 phenotype is an additional risk factor of retinopathy in type 2 diabetes mellitus.Indian journal of human genetics · 2013
   Article
8. Assessing progress in retinopathy outcomes in type 1 diabetes: comparing findings from the Wisconsin Diabetes Registry Study and the Wisconsin Epidemiologic Study of Diabetic Retinopathy.Diabetes care · 2013
   Article
9. Molecular Implications of the PPARs in the Diabetic Eye.PPAR research · 2013
   Article
10. Language barrier and its relationship to diabetes and diabetic retinopathy.BMC public health · 2012
    Article
11. Neuroprotection in diabetic retinopathy.Current diabetes reports · 2012
    Review
12. Impact of migration and acculturation on prevalence of type 2 diabetes and related eye complications in Indians living in a newly urbanised society.PloS one · 2012
    Article
13. Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy.Mediators of inflammation · 2012
    Review

Corrections and comments

• Comment on
  Progression and regression: distinct developmental patterns of diabetic retinopathy in patients with type 2 diabetes treated in the diabetes care system west-friesland, the Netherlands.2011

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as